Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
《临床泌尿生殖系统癌症》是一本同行评审期刊，发表描述泌尿生殖系统癌症临床和转化研究各个方面的原创文章。《临床泌尿生殖系统癌症》致力于发表有关泌尿生殖系统癌症的检测、诊断、预防和治疗的文章。主要强调与泌尿生殖系统恶性肿瘤相关的所有领域的最新科学发展。感兴趣的具体领域包括临床研究和机械方法;药物敏感性和耐药性;基因和反义治疗;病理学、标志物和预后指标;化学预防策略;综合疗法;以及各种方法的综合。
Neoadjuvant Chemotherapy Before Bladder‐Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle‐Invasive Bladder Cancer
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.021
Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta‐Analysis of Available Clinical Trials
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.12.011
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.003
Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.007
Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.008
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.09.006
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.011
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.013
Exploratory Investigation of Target Pazopanib Concentration Range for Patients With Renal Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.12.001
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear‐Cell and Papillary Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.10.008
Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.006
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.010
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.006
Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.08.007
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.01.015
Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.02.002
Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.017
Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal Involvement
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.10.004
Drug-Drug Interactions in Prostate Cancer Treatment.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.016
Moreau Strain Bacillus Calmette-Guérin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.003
Renal Neuroendocrine Neoplasms: A Single-center Experience.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.003
Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.03.006
Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2018.11.015
METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.12.010
Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.12.009
Denosumab Toxicity When Combined With Anti‐angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.08.006
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.008
Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.027
Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.06.002
Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.006
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.017
Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.03.012
Single Subcutaneous Prostate Cancer Metastasis Detected by 68Ga‐PSMA PET/CT During Early Biochemical Relapse: A Case Report
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.012
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.012
Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.023
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.008
Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.001
Development of a Novel Prognostic Risk Score for Predicting Complications of Penectomy in the Surgical Management of Penile Cancer
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.018
Favorable Response to Pembrolizumab in a Patient With Metastatic Castration‐Resistant Prostate Cancer Progressing While Receiving Enzalutamide
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.021
Implications of Cystectomy Travel Distance for Hospital Readmission and Survival.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.08.005
Cost‐Effectiveness of Second‐Line Treatments for Metastatic Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.010
Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.006
Targeted and Systematic Prostate Biopsy in Biopsy-naive Men With Positive Multiparameter Magnetic Resonance Imaging Findings: A Meta-analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.10.004
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.016
High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.004
Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.019
Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.002
Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.06.006
Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.08.001
Application of Everolimus in Preoperative Neoadjuvant Therapy of Tuberous Sclerosis Complex Associated With Renal Angiomyolipoma: A Single-Center Report of 5 Cases.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.005
